These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22751086)

  • 21. Naturalistic comparative study of outcome and cognitive effects of unmodified electro-convulsive therapy in schizophrenia, mania and severe depression in Nigeria.
    Ikeji OC; Ohaeri JU; Osahon RO; Agidee RO
    East Afr Med J; 1999 Nov; 76(11):644-50. PubMed ID: 10734527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are cholinergic enhancers beneficial for memory in schizophrenia? An event-related potentials (ERPs) study of rivastigmine add-on therapy in a crossover trial.
    Guillem F; Chouinard S; Poulin J; Godbout R; Lalonde P; Melun P; Bentaleb LA; Stip E
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):934-45. PubMed ID: 16580765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential long-term effects of rivastigmine on disease progression may be linked to drug effects on vascular changes in Alzheimer brains.
    Erkinjuntti T; Skoog I; Lane R; Andrews C
    Int J Clin Pract; 2003 Nov; 57(9):756-60. PubMed ID: 14686563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive function in early clinical phase huntington disease after rivastigmine treatment.
    Sešok S; Bolle N; Kobal J; Bucik V; Vodušek DB
    Psychiatr Danub; 2014 Sep; 26(3):239-48. PubMed ID: 25191771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of rivastigmine in Alzheimer's disease patients with rapid disease progression: results of a meta-analysis.
    Farlow MR; Small GW; Quarg P; Krause A
    Dement Geriatr Cogn Disord; 2005; 20(2-3):192-7. PubMed ID: 16088144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful use of donepezil in treatment of cognitive impairment caused by maintenance electroconvulsive therapy: a case report.
    Rao NP; Palaniyappan P; Chandur J; Venkatasubramanian G; Gangadhar BN
    J ECT; 2009 Sep; 25(3):216-8. PubMed ID: 19190508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cognition in elderly patients receiving unilateral and bilateral electroconvulsive therapy: a prospective, naturalistic comparison.
    O'Connor DW; Gardner B; Eppingstall B; Tofler D
    J Affect Disord; 2010 Aug; 124(3):235-40. PubMed ID: 20053457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlates of self-reported, autobiographical, and mini-mental status examination defined memory deficits following electroconvulsive therapy in South India.
    Rajkumar AP; Petit CP; Rachana A; Deinde F; Shyamsundar G; Thangadurai P; Jacob KS
    Asian J Psychiatr; 2018 Apr; 34():47-53. PubMed ID: 29635223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rivastigmine for dementia associated with Parkinson's disease.
    Emre M; Aarsland D; Albanese A; Byrne EJ; Deuschl G; De Deyn PP; Durif F; Kulisevsky J; van Laar T; Lees A; Poewe W; Robillard A; Rosa MM; Wolters E; Quarg P; Tekin S; Lane R
    N Engl J Med; 2004 Dec; 351(24):2509-18. PubMed ID: 15590953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A conceptual introduction to cognitive remediation for memory deficits associated with right unilateral electroconvulsive therapy.
    Choi J; Lisanby SH; Medalia A; Prudic J
    J ECT; 2011 Dec; 27(4):286-91. PubMed ID: 22080239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of responders and reactive domains to rivastigmine in Alzheimer's disease.
    Frankfort SV; Appels BA; de Boer A; Tulner LR; van Campen JP; Koks CH; Beijnen JH; Schmand BA
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):545-51. PubMed ID: 17109476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind randomized controlled study showing symptomatic and cognitive superiority of bifrontal over bitemporal electrode placement during electroconvulsive therapy for schizophrenia.
    Phutane VH; Thirthalli J; Muralidharan K; Naveen Kumar C; Keshav Kumar J; Gangadhar BN
    Brain Stimul; 2013 Mar; 6(2):210-7. PubMed ID: 22560048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of donepezil for the attenuation of memory deficits associated with electroconvulsive therapy.
    Dutta LCB; Sarkar CP; Andrade C
    Psychiatry Res; 2020 Nov; 293():113397. PubMed ID: 32835925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rivastigmine for Alzheimer's disease.
    Desai AK; Grossberg GT
    Expert Rev Neurother; 2005 Sep; 5(5):563-80. PubMed ID: 16162080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.
    Geretsegger C; Nickel M; Judendorfer B; Rochowanski E; Novak E; Aichhorn W
    J ECT; 2007 Dec; 23(4):239-43. PubMed ID: 18090696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is there a decline in cognitive functions after combined electroconvulsive therapy and antipsychotic therapy in treatment-refractory schizophrenia?
    Pawełczyk A; Kołodziej-Kowalska E; Pawełczyk T; Rabe-Jabłońska J
    J Nerv Ment Dis; 2015 Mar; 203(3):182-6. PubMed ID: 25668655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study.
    Poewe W; Wolters E; Emre M; Onofrj M; Hsu C; Tekin S; Lane R;
    Mov Disord; 2006 Apr; 21(4):456-61. PubMed ID: 16229010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease.
    Burn D; Emre M; McKeith I; De Deyn PP; Aarsland D; Hsu C; Lane R
    Mov Disord; 2006 Nov; 21(11):1899-907. PubMed ID: 16960863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of Electroconvulsive Therapy and Associated Cognitive Change in Schizophrenia: A Naturalistic, Comparative Study of Treating Schizophrenia With Electroconvulsive Therapy.
    Tor PC; Ying J; Ho NF; Wang M; Martin D; Ang CP; Tan C; Yap LS; Lu VJM; Simpson B; Mok YM; Loo C
    J ECT; 2017 Dec; 33(4):272-277. PubMed ID: 28640170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.